annual CFO:
-$157.78M-$50.49M(-47.06%)Summary
- As of today (July 4, 2025), CLDX annual cash flow from operations is -$157.78 million, with the most recent change of -$50.49 million (-47.06%) on December 31, 2024.
- During the last 3 years, CLDX annual CFO has fallen by -$96.87 million (-159.04%).
- CLDX annual CFO is now -963.12% below its all-time high of $18.28 million, reached on December 31, 2008.
Performance
CLDX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$54.37M-$21.90M(-67.42%)Summary
- As of today (July 4, 2025), CLDX quarterly cash flow from operations is -$54.37 million, with the most recent change of -$21.90 million (-67.42%) on March 31, 2025.
- Over the past year, CLDX quarterly CFO has dropped by -$13.73 million (-33.80%).
- CLDX quarterly CFO is now -246.61% below its all-time high of $37.09 million, reached on March 31, 2006.
Performance
CLDX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$171.51M-$13.73M(-8.70%)Summary
- As of today (July 4, 2025), CLDX TTM cash flow from operations is -$171.51 million, with the most recent change of -$13.73 million (-8.70%) on March 31, 2025.
- Over the past year, CLDX TTM CFO has dropped by -$52.15 million (-43.69%).
- CLDX TTM CFO is now -588.43% below its all-time high of $35.12 million, reached on March 31, 2006.
Performance
CLDX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CLDX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.1% | -33.8% | -43.7% |
| 3 y3 years | -159.0% | -121.6% | -154.6% |
| 5 y5 years | -239.9% | -349.0% | -277.2% |
CLDX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -159.0% | at low | -186.3% | +1.7% | -120.8% | at low |
| 5 y | 5-year | -290.5% | at low | -943.4% | +1.7% | -324.5% | at low |
| alltime | all time | -963.1% | at low | -246.6% | +1.7% | -588.4% | at low |
CLDX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$54.37M(+67.4%) | -$171.51M(+8.7%) |
| Dec 2024 | -$157.78M(+47.1%) | -$32.48M(-41.3%) | -$157.78M(-0.0%) |
| Sep 2024 | - | -$55.34M(+88.7%) | -$157.84M(+29.9%) |
| Jun 2024 | - | -$29.33M(-27.8%) | -$121.49M(+1.8%) |
| Mar 2024 | - | -$40.64M(+24.9%) | -$119.36M(+11.2%) |
| Dec 2023 | -$107.29M(+3.4%) | -$32.53M(+71.3%) | -$107.29M(+11.2%) |
| Sep 2023 | - | -$18.99M(-30.2%) | -$96.52M(-14.4%) |
| Jun 2023 | - | -$27.20M(-4.8%) | -$112.72M(+4.6%) |
| Mar 2023 | - | -$28.57M(+31.3%) | -$107.77M(+3.9%) |
| Dec 2022 | -$103.73M(+70.3%) | -$21.76M(-38.2%) | -$103.73M(+7.5%) |
| Sep 2022 | - | -$35.19M(+58.2%) | -$96.49M(+24.2%) |
| Jun 2022 | - | -$22.24M(-9.3%) | -$77.67M(+15.3%) |
| Mar 2022 | - | -$24.53M(+68.9%) | -$67.36M(+10.6%) |
| Dec 2021 | -$60.91M(+50.7%) | -$14.52M(-11.3%) | -$60.91M(+18.0%) |
| Sep 2021 | - | -$16.37M(+37.2%) | -$51.60M(+9.6%) |
| Jun 2021 | - | -$11.93M(-34.0%) | -$47.09M(+1.5%) |
| Mar 2021 | - | -$18.08M(+247.0%) | -$46.38M(+14.8%) |
| Dec 2020 | -$40.40M(-13.0%) | -$5.21M(-56.1%) | -$40.40M(-12.5%) |
| Sep 2020 | - | -$11.86M(+5.7%) | -$46.19M(+1.6%) |
| Jun 2020 | - | -$11.22M(-7.3%) | -$45.47M(+0.4%) |
| Mar 2020 | - | -$12.11M(+10.1%) | -$45.29M(-2.4%) |
| Dec 2019 | -$46.41M(-38.3%) | -$11.00M(-1.3%) | -$46.41M(-8.7%) |
| Sep 2019 | - | -$11.14M(+0.9%) | -$50.84M(-6.0%) |
| Jun 2019 | - | -$11.04M(-16.6%) | -$54.09M(-10.5%) |
| Mar 2019 | - | -$13.23M(-14.2%) | -$60.45M(-19.7%) |
| Dec 2018 | -$75.23M(-24.7%) | -$15.43M(+7.2%) | -$75.23M(-5.2%) |
| Sep 2018 | - | -$14.39M(-17.3%) | -$79.33M(-11.2%) |
| Jun 2018 | - | -$17.39M(-37.9%) | -$89.30M(-3.7%) |
| Mar 2018 | - | -$28.02M(+43.5%) | -$92.69M(-7.2%) |
| Dec 2017 | -$99.93M(-11.6%) | -$19.52M(-19.9%) | -$99.93M(-0.8%) |
| Sep 2017 | - | -$24.36M(+17.2%) | -$100.76M(+0.4%) |
| Jun 2017 | - | -$20.79M(-41.0%) | -$100.35M(-11.5%) |
| Mar 2017 | - | -$35.26M(+73.3%) | -$113.40M(+0.3%) |
| Dec 2016 | -$113.04M(+14.3%) | -$20.35M(-15.1%) | -$113.04M(+6.2%) |
| Sep 2016 | - | -$23.95M(-29.2%) | -$106.43M(-3.5%) |
| Jun 2016 | - | -$33.83M(-3.1%) | -$110.27M(+9.0%) |
| Mar 2016 | - | -$34.90M(+153.9%) | -$101.20M(+2.3%) |
| Dec 2015 | -$98.89M(-2.6%) | -$13.74M(-50.5%) | -$98.89M(-7.9%) |
| Sep 2015 | - | -$27.79M(+12.2%) | -$107.36M(+1.1%) |
| Jun 2015 | - | -$24.76M(-24.0%) | -$106.16M(+3.8%) |
| Mar 2015 | - | -$32.59M(+46.7%) | -$102.25M(+0.7%) |
| Dec 2014 | -$101.54M(+50.0%) | -$22.21M(-16.5%) | -$101.54M(+7.7%) |
| Sep 2014 | - | -$26.59M(+27.5%) | -$94.28M(+10.7%) |
| Jun 2014 | - | -$20.86M(-34.6%) | -$85.14M(+3.4%) |
| Mar 2014 | - | -$31.88M(+113.1%) | -$82.34M(+21.7%) |
| Dec 2013 | -$67.67M(+35.9%) | -$14.96M(-14.3%) | -$67.67M(+2.5%) |
| Sep 2013 | - | -$17.45M(-3.3%) | -$66.04M(+10.9%) |
| Jun 2013 | - | -$18.06M(+5.0%) | -$59.53M(+11.4%) |
| Mar 2013 | - | -$17.20M(+29.1%) | -$53.43M(+7.3%) |
| Dec 2012 | -$49.78M(+39.6%) | -$13.33M(+21.8%) | -$49.78M(+8.6%) |
| Sep 2012 | - | -$10.94M(-8.5%) | -$45.83M(+6.7%) |
| Jun 2012 | - | -$11.96M(-11.8%) | -$42.94M(+6.4%) |
| Mar 2012 | - | -$13.55M(+44.6%) | -$40.35M(+13.1%) |
| Dec 2011 | -$35.66M(+17.4%) | -$9.37M(+16.3%) | -$35.66M(+10.4%) |
| Sep 2011 | - | -$8.06M(-13.9%) | -$32.30M(+1.0%) |
| Jun 2011 | - | -$9.37M(+5.7%) | -$31.99M(-1.0%) |
| Mar 2011 | - | -$8.86M(+47.4%) | -$32.30M(+6.3%) |
| Dec 2010 | -$30.37M(+1.7%) | -$6.01M(-22.3%) | -$30.37M(-13.7%) |
| Sep 2010 | - | -$7.74M(-20.0%) | -$35.20M(+6.8%) |
| Jun 2010 | - | -$9.68M(+39.4%) | -$32.96M(+5.4%) |
| Mar 2010 | - | -$6.94M(-36.0%) | -$31.26M(+4.7%) |
| Dec 2009 | -$29.87M(-263.4%) | -$10.84M(+97.0%) | -$29.87M(+68.4%) |
| Sep 2009 | - | -$5.50M(-31.0%) | -$17.73M(-16.4%) |
| Jun 2009 | - | -$7.97M(+43.6%) | -$21.21M(-224.5%) |
| Mar 2009 | - | -$5.55M(-528.9%) | $17.04M(-6.8%) |
| Dec 2008 | $18.28M(-300.3%) | $1.29M(-114.4%) | $18.28M(+34.1%) |
| Sep 2008 | - | -$8.98M(-129.7%) | $13.63M(-50.6%) |
| Jun 2008 | - | $30.27M(-802.9%) | $27.56M(-351.4%) |
| Mar 2008 | - | -$4.31M(+28.2%) | -$10.96M(+20.1%) |
| Dec 2007 | -$9.13M | -$3.36M(-167.8%) | -$9.13M(-81.1%) |
| Sep 2007 | - | $4.95M(-160.0%) | -$48.38M(-15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$8.25M(+234.1%) | -$57.20M(+7.5%) |
| Mar 2007 | - | -$2.47M(-94.2%) | -$53.20M(+290.0%) |
| Dec 2006 | -$13.64M(+126.7%) | -$42.61M(+1003.0%) | -$13.64M(-143.9%) |
| Sep 2006 | - | -$3.86M(-9.1%) | $31.05M(+1.3%) |
| Jun 2006 | - | -$4.25M(-111.5%) | $30.66M(-12.7%) |
| Mar 2006 | - | $37.09M(+1688.2%) | $35.12M(-683.6%) |
| Dec 2005 | -$6.02M(-41.9%) | $2.07M(-148.8%) | -$6.02M(-48.3%) |
| Sep 2005 | - | -$4.25M(-2139.3%) | -$11.63M(+12.0%) |
| Jun 2005 | - | $208.60K(-105.2%) | -$10.38M(-15.1%) |
| Mar 2005 | - | -$4.05M(+14.4%) | -$12.24M(+18.3%) |
| Dec 2004 | -$10.35M(-11.9%) | -$3.54M(+17.4%) | -$10.35M(+2.5%) |
| Sep 2004 | - | -$3.01M(+83.1%) | -$10.10M(+3.0%) |
| Jun 2004 | - | -$1.64M(-23.7%) | -$9.80M(-9.4%) |
| Mar 2004 | - | -$2.16M(-34.3%) | -$10.82M(-7.8%) |
| Dec 2003 | -$11.74M(-29.5%) | -$3.28M(+20.7%) | -$11.74M(+25.1%) |
| Sep 2003 | - | -$2.72M(+2.4%) | -$9.38M(-20.6%) |
| Jun 2003 | - | -$2.66M(-13.6%) | -$11.82M(-17.5%) |
| Mar 2003 | - | -$3.08M(+231.9%) | -$14.33M(-14.0%) |
| Dec 2002 | -$16.66M(-20.0%) | -$927.10K(-82.0%) | -$16.66M(-21.4%) |
| Sep 2002 | - | -$5.16M(-0.0%) | -$21.20M(-2.7%) |
| Jun 2002 | - | -$5.16M(-4.6%) | -$21.79M(+3.9%) |
| Mar 2002 | - | -$5.41M(-1.0%) | -$20.97M(+0.7%) |
| Dec 2001 | -$20.83M(+369.9%) | -$5.47M(-5.0%) | -$20.83M(+33.1%) |
| Sep 2001 | - | -$5.75M(+32.6%) | -$15.65M(+26.1%) |
| Jun 2001 | - | -$4.34M(-17.7%) | -$12.41M(+13.9%) |
| Mar 2001 | - | -$5.27M(+1734.8%) | -$10.90M(+145.9%) |
| Dec 2000 | -$4.43M(-48.1%) | -$287.20K(-88.6%) | -$4.43M(-17.7%) |
| Sep 2000 | - | -$2.52M(-11.0%) | -$5.38M(+2.2%) |
| Jun 2000 | - | -$2.83M(-336.2%) | -$5.27M(+6.6%) |
| Mar 2000 | - | $1.20M(-196.6%) | -$4.94M(-42.1%) |
| Dec 1999 | -$8.54M(-4.1%) | -$1.24M(-48.4%) | -$8.54M(+1.7%) |
| Sep 1999 | - | -$2.40M(-4.0%) | -$8.40M(-14.3%) |
| Jun 1999 | - | -$2.50M(+4.2%) | -$9.80M(+4.3%) |
| Mar 1999 | - | -$2.40M(+118.2%) | -$9.40M(+5.6%) |
| Dec 1998 | -$8.90M(+15.6%) | -$1.10M(-71.1%) | -$8.90M(-10.1%) |
| Sep 1998 | - | -$3.80M(+81.0%) | -$9.90M(+22.2%) |
| Jun 1998 | - | -$2.10M(+10.5%) | -$8.10M(+8.0%) |
| Mar 1998 | - | -$1.90M(-9.5%) | -$7.50M(-2.6%) |
| Dec 1997 | -$7.70M(-20.6%) | -$2.10M(+5.0%) | -$7.70M(+2.7%) |
| Sep 1997 | - | -$2.00M(+33.3%) | -$7.50M(-6.3%) |
| Jun 1997 | - | -$1.50M(-28.6%) | -$8.00M(-12.1%) |
| Mar 1997 | - | -$2.10M(+10.5%) | -$9.10M(-6.2%) |
| Dec 1996 | -$9.70M(+22.8%) | -$1.90M(-24.0%) | -$9.70M(+40.6%) |
| Sep 1996 | - | -$2.50M(-3.8%) | -$6.90M(-10.4%) |
| Jun 1996 | - | -$2.60M(-3.7%) | -$7.70M(+2.7%) |
| Mar 1996 | - | -$2.70M(-400.0%) | -$7.50M(-5.1%) |
| Dec 1995 | -$7.90M(-13.2%) | $900.00K(-127.3%) | -$7.90M(-31.3%) |
| Sep 1995 | - | -$3.30M(+37.5%) | -$11.50M(+12.7%) |
| Jun 1995 | - | -$2.40M(-22.6%) | -$10.20M(0.0%) |
| Mar 1995 | - | -$3.10M(+14.8%) | -$10.20M(+12.1%) |
| Dec 1994 | -$9.10M(+65.5%) | -$2.70M(+35.0%) | -$9.10M(+23.0%) |
| Sep 1994 | - | -$2.00M(-16.7%) | -$7.40M(+12.1%) |
| Jun 1994 | - | -$2.40M(+20.0%) | -$6.60M(+11.9%) |
| Mar 1994 | - | -$2.00M(+100.0%) | -$5.90M(+7.3%) |
| Dec 1993 | -$5.50M(+41.0%) | -$1.00M(-16.7%) | -$5.50M(+22.2%) |
| Sep 1993 | - | -$1.20M(-29.4%) | -$4.50M(-6.3%) |
| Jun 1993 | - | -$1.70M(+6.3%) | -$4.80M(+14.3%) |
| Mar 1993 | - | -$1.60M(+6.7%) | -$4.20M(-4.5%) |
| Dec 1992 | -$3.90M(-4.9%) | - | - |
| Oct 1992 | - | -$1.50M(+36.4%) | -$4.40M(0.0%) |
| Jul 1992 | - | -$1.10M(-15.4%) | -$4.40M(+7.3%) |
| Apr 1992 | - | -$1.30M(+160.0%) | -$4.10M(+41.4%) |
| Apr 1992 | -$4.10M(+36.7%) | - | - |
| Jan 1992 | - | -$500.00K(-66.7%) | -$2.90M(-14.7%) |
| Oct 1991 | - | -$1.50M(+87.5%) | -$3.40M(-2.9%) |
| Jul 1991 | - | -$800.00K(+700.0%) | -$3.50M(+16.7%) |
| Apr 1991 | -$3.00M(+328.6%) | -$100.00K(-90.0%) | -$3.00M(+3.4%) |
| Jan 1991 | - | -$1.00M(-37.5%) | -$2.90M(+52.6%) |
| Oct 1990 | - | -$1.60M(+433.3%) | -$1.90M(+533.3%) |
| Jul 1990 | - | -$300.00K | -$300.00K |
| Apr 1990 | -$700.00K | - | - |
FAQ
- What is Celldex Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Celldex Therapeutics?
- What is Celldex Therapeutics annual CFO year-on-year change?
- What is Celldex Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly CFO year-on-year change?
- What is Celldex Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Celldex Therapeutics?
- What is Celldex Therapeutics TTM CFO year-on-year change?
What is Celldex Therapeutics annual cash flow from operations?
The current annual CFO of CLDX is -$157.78M
What is the all time high annual CFO for Celldex Therapeutics?
Celldex Therapeutics all-time high annual cash flow from operations is $18.28M
What is Celldex Therapeutics annual CFO year-on-year change?
Over the past year, CLDX annual cash flow from operations has changed by -$50.49M (-47.06%)
What is Celldex Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CLDX is -$54.37M
What is the all time high quarterly CFO for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly cash flow from operations is $37.09M
What is Celldex Therapeutics quarterly CFO year-on-year change?
Over the past year, CLDX quarterly cash flow from operations has changed by -$13.73M (-33.80%)
What is Celldex Therapeutics TTM cash flow from operations?
The current TTM CFO of CLDX is -$171.51M
What is the all time high TTM CFO for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM cash flow from operations is $35.12M
What is Celldex Therapeutics TTM CFO year-on-year change?
Over the past year, CLDX TTM cash flow from operations has changed by -$52.15M (-43.69%)